Halloween Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
IPO.TO 0.93TOT.TO 1.08EFX.TO 4.85IXC 0.82VDY.TO 1.5CM.TO 2.81XOM 1.93LLY -16.11
Neurochem (NRM.TO)

Neurochem (NRM.TO)

Neurochem (NRM.TO) is covered by Stockchase stock experts. Read their latest opinions, ratings and top picks below.

0.00
-0.00 (0.00%)
0 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
COMMENT

Neurochem(NRM.TO)

Jul 04, 2022
The name of the company was indistinct and this is the closest result in the data base. It is a biotech company focused on brain health. It acquired an AI company called Metro Mark. It is signing more and more deals with pharmaceutical companies for up-front and royalty payments.
Photo of Bruce Campbell (2)Bruce Campbell (2)Unlock Rating
N/A

Stock price when the opinion was issued

biotechnologypharmaceutical
SELL

Neurochem(NRM.TO)

Feb 23, 2006
He likes it, the only downside is that because the Japaneese market has risen 40% over the last year, it's a bit expensive right now. He suggests going to a different fund which is not so centered on the Japaneese market.
Photo of David DriscollDavid DriscollUnlock Rating
$17.60

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Neurochem(NRM.TO)

Apr 27, 2005
Looking at his relative performer chart, it's been an underperformer. Has negative money flow. In a very clear downtrend.
Photo of Bill CarriganBill Carrigan
No
Unlock Rating
$9.16

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Neurochem(NRM.TO)

Jul 28, 2004
There has been a general selloff of biotech stocks. Still believe in this company.
Photo of Michael SmedleyMichael Smedley
Owned
Unlock Rating
$22.85

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Neurochem(NRM.TO)

Jul 08, 2004
Feels it's a little pricey at these levels given where they are in the development of their program. Have some interesting programs.
Photo of Andrew McCreathAndrew McCreath
No
Unlock Rating
$28.68

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Neurochem(NRM.TO)

Mar 23, 2004
Has been moving sideways which, for a biotech, is not too bad. The company has good backing. Should see considerable upside.
Photo of Michael SmedleyMichael SmedleyUnlock Rating
$26.60

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Neurochem(NRM.TO)

Jan 23, 2004
(A top pick Sept 9/03. Up100 %.) Still likes. The market opportunity is so big, would still buy at this price.
Photo of Peter HodsonPeter Hodson
Owned
Unlock Rating
$29.10

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Neurochem(NRM.TO)

Dec 04, 2003
(A top pick Sept 9/03. Up 58%.) As a potential treatment for Alzheimer's. Good technology. Has some US financing which will get US investors interested.
Photo of Peter HodsonPeter Hodson
Owned
Unlock Rating
$22.91

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Neurochem(NRM.TO)

Sep 09, 2003
Into phase 3 trial. All cashed up. Will start to be getting attention.
Photo of Peter HodsonPeter Hodson
Owned
Unlock Rating
$14.20

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Neurochem(NRM.TO)

Aug 08, 2003
Has a very strong range of products.
Photo of Michael SmedleyMichael Smedley
Owned
Unlock Rating
$12.97

Stock price when the opinion was issued

biotechnologypharmaceutical
HOLD

Neurochem(NRM.TO)

Jan 20, 2003
Has gone up quite well and may stay level for awhile.
Photo of Pierre BernardPierre BernardUnlock Rating
$8.40

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Neurochem(NRM.TO)

Jan 14, 2003
Likes the managemnt. Big financial support.
Photo of Michael SmedleyMichael SmedleyUnlock Rating
$8.32

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 1 to 12 of 12 entries
  • «
  • ‹
  • 1
  • ›
  • »

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

KEY.TO 0.45$54.96
XEG.TO 1.14$30.54
WCP.TO 0.62$19.31
VET.TO 0.52$17.43
BTE.TO 0.25$7.12

Today's Top Picks

IPO.TO 0.93$18.75
TOT.TO 1.08$36.67
EFX.TO 4.85$39.11
IXC 0.82$60.7
VDY.TO 1.5$76.84

Popular Articles

Latest Sell Signals

TRP.TO 2$87.69
TOU.TO 1.26$65.19
PEY.TO 0.52$24.79
AMBA -3.32$64.11
AMRC -0.43$20.9

Most Recent Experts

Jerome Hass

Jerome Hass

Lightwater Partners

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Brian Madden

Brian Madden

First Avenue Investment Counsel

Jamie Murray

Jamie Murray

Murray Wealth Group

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Neurochem (NRM.TO) Frequently Asked Questions

What is Neurochem stock symbol?

Neurochem is a OTC stock, trading under the symbol NRM.TO (previously NRM-T on Stockchase) on the undefined (undefined). It is usually referred to as or NRM.TO

Is Neurochem a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on NRM.TO (previously NRM-T on Stockchase) on Stockchase. Read the latest expert commentary for Neurochem.

Is Neurochem a good investment or a top pick?

Neurochem was recommended as a Top Pick by Bruce Campbell (2) on 2022-07-04. Read the latest stock experts ratings for Neurochem.

Why is Neurochem stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Neurochem.

Is Neurochem worth watching?

Neurochem is covered by Stockchase experts and is worth watching.